Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults.
Sumazin P, Peters TL, Sarabia SF, Kim HR, Urbicain M, Hollingsworth EF, Alvarez KR, Perez CR, Pozza A, Najaf Panah MJ, Epps JL, Scorsone K, Zorman B, Katzenstein H, O'Neill AF, Meyers R, Tiao G, Geller J, Ranganathan S, Rangaswami AA, Woodfield SE, Goss JA, Vasudevan SA, Heczey A, Roy A, Fisher KE, Alaggio R, Patel KR, Finegold MJ, López-Terrada DH. Sumazin P, et al. Among authors: katzenstein h. J Hepatol. 2022 Oct;77(4):1026-1037. doi: 10.1016/j.jhep.2022.04.035. Epub 2022 May 14. J Hepatol. 2022. PMID: 35577029 Free PMC article.
Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study.
Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Liu-Mares W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC. Katzenstein HM, et al. J Clin Oncol. 2002 Jun 15;20(12):2789-97. doi: 10.1200/JCO.2002.06.155. J Clin Oncol. 2002. PMID: 12065555 Clinical Trial.
Fibrolamellar hepatocellular carcinoma in children and adolescents.
Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Qu W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC. Katzenstein HM, et al. Cancer. 2003 Apr 15;97(8):2006-12. doi: 10.1002/cncr.11292. Cancer. 2003. PMID: 12673731 Free article. Review.
Predictive value of staging systems in hepatoblastoma.
Meyers RL, Katzenstein HM, Malogolowkin MH. Meyers RL, et al. Among authors: katzenstein hm. J Clin Oncol. 2007 Feb 20;25(6):737; author reply 737-8. doi: 10.1200/JCO.2006.06.4915. J Clin Oncol. 2007. PMID: 17308285 No abstract available.
Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group.
Katzenstein HM, Chang KW, Krailo M, Chen Z, Finegold MJ, Rowland J, Reynolds M, Pappo A, London WB, Malogolowkin M; Children's Oncology Group. Katzenstein HM, et al. Cancer. 2009 Dec 15;115(24):5828-35. doi: 10.1002/cncr.24667. Cancer. 2009. PMID: 19813275 Free PMC article. Clinical Trial.
106 results